Skip to main content

Published locations for Ibrutinib at below standard dose may achieve good survival in CLL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ibrutinib at below standard dose may achieve good survival in CLL

User login

  • Reset your password
  • /content/ibrutinib-below-standard-dose-may-achieve-good-survival-cll
  • /hematologynews/article/109835/cll/ibrutinib-below-standard-dose-may-achieve-good-survival-cll
  • /oncologypractice/article/109835/cll/ibrutinib-below-standard-dose-may-achieve-good-survival-cll
  • /hematology-oncology/article/109835/cll/ibrutinib-below-standard-dose-may-achieve-good-survival-cll
  • /b-cell-lymphoma-icymi/article/109835/cll/ibrutinib-below-standard-dose-may-achieve-good-survival-cll